Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Basel Ramlawi, MD
Paramount Heart
Principal Investigator - John Forrest, MD
Yale University
Principal Investigator - Michael Reardon, MD
The Methodist Hospital Research Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Abrazo Arizona Heart Hospital
Phoenix, Arizona, United States
- Scripps Memorial Hospital la Jolla
La Jolla, California, United States
- Los Robles Hospital & Medical Center
Thousand Oaks, California, United States
- Yale New Haven Hospital
New Haven, Connecticut, United States
- Morton Plant Hospital
Clearwater, Florida, United States
- Healthpark Medical Center
Fort Myers, Florida, United States
- Tallahassee Memorial Hospital
Tallahassee, Florida, United States
- Piedmont Atlanta Hospital
Atlanta, Georgia, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Spectrum Health Hospital
Grand Rapids, Michigan, United States
- Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
- North Shore University Hospital
Manhasset, New York, United States
- the Mount Sinai Hospital
New York, New York, United States
- Saint Francis Hospital
Roslyn, New York, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Ohiohealth Riverside Methodist Hospital
Columbus, Ohio, United States
- Oregon Health & Science University Hospital
Portland, Oregon, United States
- Upmc Pinnacle Harrisburg Campus
Harrisburg, Pennsylvania, United States
- Paramount Heart
Villanova, Pennsylvania, United States
- Baylor Jack and Jane Hamilton Heart & Vascular Hospital
Dallas, Texas, United States
- Houston Methodist Hospital
Houston, Texas, United States
- Aurora St. Luke'S Medical Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Oct 2018
- Primary completion
- 13 Nov 2019
- Completion
- 31 Dec 2030
- Last update posted
- 5 May 2026
- Registered enrollment
- 150
- Registry id
- NCT03635424
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.